School of Immunology & Microbial Sciences

King’s Centre for Lung Health

The King’s Centre for Lung Health (KCLH) brings together expertise across the Respiratory Sciences (e.g. Biology, Immunology, Infection, Pharmacology, Physiology, Imaging, and Clinical Trials) across the interface of Lung Disease (some examples include Asthma, COPD, ILD). We strive to be inclusive, with a vision to eliminate lung disease by prevention, early diagnosis and better treatments.

We work together across groups, across departments and across sites to lead as a world class centre of Respiratory excellence. We are leading the field in understanding mechanisms of disease, molecular diagnostics and novel treatments of lung diseases.

King's Centre for Lung Health

Promoting lung health throughout the lifetime, by preventing, diagnosing and treating lung disease.

Clinical Diagnostics Development Unit (CDDU)

The CDDU ethos is to harmonise all methods used within the labs for the processing of clinical samples.

Fear Lab

The Fear Lab is currently investigating molecular mechanisms regulating Human B cell germinal centre activities.

Hawrylowicz Group

This group addresses the importance of vitamin D sufficiency for respiratory health throughout the life course and the immune mechanisms that underpin this

Martinez-Nunez Group

We investigate how mRNA translation is regulated during inflammation and infection responses.

Respiratory Epigenetics

The objective of the research is to identify disease-specific epigenetic landscapes, the factors that drive reorganization, the enzymes that they utilize to achieve these functions and the transcriptional consequences of reorganization.

Santis Group

We study the role of Coxsackie B virus and Adenovirus receptor (CAR) in airway inflammation and cancer. We also evaluate EGFR oligomerisation in lung cancer cells as a biomarker for disease severity and response to treatment.

Schurich Group

The Schurich Lab studies the function of human T cells, with a focus on T cell metabolism to understand how T cells fuel their extraordinary effector capacity.

Till Group

Working on development of novel forms of immunotherapy to treat allergic diseases.

Warnatsch Group

The Warnatsch group studies the localisation and effects of neutrophil reactive oxygen species (ROS) during respiratory virus infections.

Woszczek Group

Our research focuses around role of lipid mediators in pathomechanisms of chronic inflammatory diseases such as asthma, rhinosinusitis and allergy. Using newly developed molecular and cellular biology methods we characterise functions and signalling of G-protein coupled receptors for eicosanoids (leukotrienes, prostaglandins) and sphingolipids (sphingosine-1-phosphate) and their role in immune response.

Professor Mona Bafadhel

Chair of Respiratory Medicine
Dr David Fear

Senior Lecturer
Professor Catherine Hawrylowicz

Professor of Immune Regulation in Allergic Diseases
Dr Mohammad Ibrahim

Honorary Reader
Dr Greg Knock

Senior Lecturer in Physiology
Professor Gideon Lack

Professor of Paediatric Allergy
Dr Paul Lavender

Reader in Respiratory Epigenetics
Dr Rocio Martinez-Nunez

Reader in RNA Biology and Immunity
Dr Richard Russell

Interim Head of Department, Peter Gorer Department of Immunobiology
Professor Alexandra Santos

Clinical Professor of Paediatric Food Allergy
Dr Anna Schurich

Senior Lecturer
Professor Stephen Till

Professor of Allergy
Professor Annapurna Vyakarnam

Professor of Microbial Immunology
Dr Annika Warnatsch

Sir Henry Dale Fellow
Dr Grzegorz Woszczek

Senior Lecturer